Latest Sofinnova Partners Stories
SAN FRANCISCO, May 16, 2014 /PRNewswire/ -- OpenERP has raised $10 million dollars in funding to support its R&D efforts and commercial growth.
CAMBRIDGE, England, April 3, 2014 /PRNewswire/ -- GBP19.5M raised to drive development of best-in-class fully human VH antibody
AMSTERDAM, The Netherlands, June 9, 2011 /PRNewswire/ -- Avantium is proud to announce that it has successfully raised EUR 30 million to advance its breakthrough YXY technology for green building blocks.
MINNEAPOLIS, MN, May 4 /PRNewswire/ - BioAmber Inc., the market leader in biobased succinic acid, has raised $45 million dollars in a Series B financing that will accelerate the commercialization of succinic acid and modified PBS.
BEDMINSTER, N.J., March 14, 2011 /PRNewswire/ -- Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that it has raised $33.9 million in a Series B funding round, led by new investor, New Enterprise Associates ("NEA"), one of the world's leading venture capital firms.
PARIS, July 1, 2010 /PRNewswire/ -- - EUR 13.7m Second Round Funding Sofinnova Partners, acting as a leading investor, Gimv and Amundi Private Equity Funds announced today their investment in McPhy Energy, together with the historic investors in a second round of funding worth EUR 13.7m.
MARSEILLE, France, May 4, 2010 /PRNewswire/ -- WYPLAY SAS, a pioneer in the development of the High-Definition Media Center, today announced it has closed a 9 million euro third round of financing. Amundi Private Equity Funds, who led this 3rd round, was joined by A Plus Finance, Elaia Partners and Sofinnova Partners, Wyplay's second round lead investors reflecting their continued confidence in the company.
- An armed gangster.